由MSC中的小细胞外囊泡输送的microRNAs作为骨再生的新兴工具
Runyuan Liu1, Saixuan Wu1, Wanqing Liu1
1School of Stomatology, Dalian Medical University, Dalian, China.
Frontiers in bioengineering and biotechnology
|September 18, 2023
概括
介酶干细胞的小细胞外囊泡 (MSCs-sEVs) 提供微RNA (miRNAs) 来增强骨再生. 本次审查强调MSCs-sEVs作为有效的miRNA输送载体,用于骨组织工程和疾病.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
背景情况:
- 骨再生涉及复杂的细胞过程,包括血管新生,骨质新生和骨质结晶新生.
- 在组织工程中,介质干细胞 (MSC) 对于恢复骨质平衡至关重要.
- 来自MSCs (MSCs-sEVs) 的小细胞外囊泡 (sEVs) 通过近信号传递介导治疗效果.
研究的目的:
- 审查最近利用MSCs-sEVs提供的miRNAs用于骨再生的进展.
- 探索MSCs-sEVs在治疗骨疾病中的治疗潜力.
- 在各种微环境条件下总结骨质性MSCs-sEVs中的miRNA表达特征.
主要方法:
- 文献综述侧重于涉及MSCs-sEVs和miRNA输送用于骨再生的研究.
- 分析MSCs-sEVs衍生的miRNAs影响受体细胞基因表达的机制.
- 关于MSCs-sEVs与骨质生成相关的miRNA表达变化的数据汇编.
主要成果:
- MSCs-sEVs作为有效的自然纳米载体来传递miRNA,增强骨再生.
- 从MSCs-sEVs传递的miRNAs可以调节基因表达,以促进骨质生成和骨愈合.
- 在不同的条件下了解MSCs-sEVs中的miRNA表达是优化其治疗用途的关键.
结论:
- MSCs-sEVs代表了一种有希望的无细胞治疗策略,用于骨再生和治疗骨缺陷.
- MSCs-sEVs的稳定性和生物可用性克服了传统miRNA疗法的局限性.
- 对MSCs-sEV及其miRNA载荷的进一步研究将促进骨组织工程应用.
相关概念视频
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
MicroRNAs
21.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.4K


